Skip to main content
Clinical Trials/NL-OMON43841
NL-OMON43841
Completed
Phase 2

Staging laparoscopy combined with ultrasonography and near-infrared fluorescence imaging to detect occult pancreatic metastases - NIRF stadieringslaparoscopy

eids Universitair Medisch Centrum0 sites25 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Pancreatic cancer metastases
Sponsor
eids Universitair Medisch Centrum
Enrollment
25
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- 18 years or older;
  • \- Patients with pancreatic or periampullary cancer undergoing staging laparoscopy
  • \- Absence of any psychological, familial sociological or geographical condition potentially hampering compliance with the study protocol and follow\-up schedule; those conditions should be discussed with the patient before registration in the trial;
  • \- Before patient registration, written consent must be given according to ICH/GCP, national and local regulations.

Exclusion Criteria

  • \- History of allergy to iodine, shellfish or ICG;
  • \- Renal impairment, defined as eGFR \> 60;
  • \- Patients with hyperthyroidism;
  • \- Pregnant or lactating woman;
  • \- Any condition that in the opinion of the investigator could potentially jeopardize the health status of the patient.

Outcomes

Primary Outcomes

Not specified

Similar Trials